News
Kit for depression diagnosis through blood analysis wins Innovation prize from Exame Informática.
i3S, IPO-Porto and Phyzat, a biopharmaceutical company, teamed up to venture into the development of a new cancer therapy.
i3S team receives scholarship to study bone lesions caused by multiple myeloma.
Therapy to boost nervous system regeneration wins Bluepharma Innovation Award / University of Coimbra 2017.
With so many people suffering from lower back pain, this newly secured funding awarded by EUROSPINE to i3S could mean good news in the future.
Isabel Cardoso and her team just got awarded funding by Fundação Millennium. An important contribution to pursue their research on Alzheimer's.
This year's winner of the Crioestaminal Prize is i3S researcher Nuno Alves!
IMUNOLINF earned i3S researcher Nuno Santos a Gilead GÉNESE Program grant.
The institute’s contribution to regional development was acknowledged by the EC placing i3S in the final stage of the RegioStars Awards.